Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study

被引：0

作者：

Ryohei Yamamoto

Enyu Imai

Shoichi Maruyama

Hitoshi Yokoyama

Hitoshi Sugiyama

Asami Takeda

Tatsuo Tsukamoto

Shunya Uchida

Kazuhiko Tsuruya

Tatsuya Shoji

Hiroki Hayashi

Yasuhiro Akai

Megumu Fukunaga

Tsuneo Konta

Saori Nishio

Shunsuke Goto

Hirofumi Tamai

Kojiro Nagai

Ritsuko Katafuchi

Kosuke Masutani

Takashi Wada

Tomoya Nishino

Arimasa Shirasaki

Hiroshi Sobajima

Kosaku Nitta

Kunihiro Yamagata

Junichiro J. Kazama

Keiju Hiromura

Hideo Yasuda

Makoto Mizutani

Toshiyuki Akahori

Tomohiko Naruse

Takeyuki Hiramatsu

Kunio Morozumi

Tetsushi Mimura

Yosuke Saka

Eiji Ishimura

Hajime Hasegawa

Daisuke Ichikawa

Takashi Shigematsu

Hiroshi Sato

Ichiei Narita

Yoshitaka Isaka

机构：

[1] Osaka University,Health and Counseling Center

[2] Osaka University Graduate School of Medicine,Department of Nephrology

[3] Nakayamadera Imai Clinic,Department of Nephrology

[4] Nagoya University Graduate School of Medicine,Department of Nephrology

[5] Kanazawa Medical University School of Medicine,Department of Nephrology, Rheumatology, Endocrinology and Metabolism

[6] Okayama University Graduate School of Medicine,Kidney Disease Center

[7] Dentistry and Pharmaceutical Sciences,Department of Nephrology and Dialysis

[8] Japanese Red Cross Nagoya Daini Hospital,Department of Internal Medicine

[9] Kitano Hospital,Department of Nephrology

[10] Tazuke Kofukai Medical Research Institute,Department of Kidney Disease and Hypertension

[11] Teikyo University School of Medicine,Department of Nephrology

[12] Nara Medical University,First Department of Internal Medicine

[13] Osaka General Medical Center,Division of Nephrology, Department of Internal Medicine

[14] Fujita Health University School of Medicine,Department of Cardiology, Pulmonology, and Nephrology

[15] Nara Medical University,Division of Rheumatology, Endocrinology and Nephrology

[16] Toyonaka Municipal Hospital,Division of Nephrology and Kidney Center

[17] Yamagata University School of Medicine,Department of Nephrology

[18] Hokkaido University Graduate School of Medicine,Department of Nephrology, Institute of Biomedical Sciences

[19] Kobe University Graduate School of Medicine,Kidney Unit

[20] Anjo Kosei Hospital,Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine

[21] Tokushima University Graduate School,Department of Nephrology and Laboratory Medicine

[22] National Hospital Organization Fukuokahigashi Medical Center,Department of Nephrology

[23] Fukuoka University,Department of Nephrology

[24] Kanazawa University,Department of Diabetology and Nephrology

[25] Nagasaki University Hospital,Department of Nephrology

[26] Ichinomiya Municipal Hospital,Department of Nephrology, Faculty of Medicine

[27] Ogaki Municipal Hospital,Department of Nephrology and Hypertension

[28] Tokyo Women’s Medical University,Department of Nephrology and Rheumatology

[29] University of Tsukuba,Internal Medicine 1

[30] Fukushima Medical University School of Medicine,Department of Nephrology

[31] Gunma University Graduate School of Medicine,Department of Nephrology

[32] Hamamatsu University School of Medicine,Department of Nephrology

[33] Handa City Hospital,Department of Nephrology

[34] Chutoen General Medical Center,Department of Nephrology

[35] Kasugai Municipal Hospital,Department of Nephrology

[36] Konan Kosei Hospital,Department of Nephrology

[37] Masuko Memorial Hospital,Department of Nephrology

[38] Gifu Prefectural Tajimi Hospital,Department of Nephrology and Hypertension

[39] Yokkaichi Municipal Hospital,Division of Nephrology and Hypertension, Department of Internal Medicine

[40] Osaka City University Graduate School of Medicine,Department of Nephrology

[41] Saitama Medical Center,Department of Nephrology, Endocrinology, and Vascular Medicine

[42] Saitama Medical University,Division of Clinical Nephrology and Rheumatology, Kidney Research Center

[43] St. Marianna University School of Medicine,undefined

[44] Wakayama Medical University,undefined

[45] Tohoku University Graduate School of Medicine,undefined

[46] Niigata University Graduate School of Medical and Dental Sciences,undefined

来源：

Journal of Nephrology | 2022年 / 35卷

关键词：

Minimal change disease; Focal segmental glomerulosclerosis; Relapse of proteinuria; Japan Nephrotic Syndrome Cohort Study (JNSCS);

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1135 / 1144

页数：9

共 49 条

[41] The initial time to remission after steroid treatment predicts the subsequent course of minimal change nephrotic syndrome: a retrospective study
Moscaritolo, E.
Massella, L.
Emma, F.
PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1535 - 1535
[42] An adolescent with relapsing nephrotic syndrome: Minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy
Shappell, SB
Myrthil, G
Fogo, A
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (06) : 966 - 970
[43] RITUXIMAB IS AN EFFECTIVE THERAPY FOR CALCINEURIN INHIBITOR RESISTANT/DEPENDENT OR INTOLERANT NEPHROTIC SYNDROME DUE TO IDIOPATHIC MINIMAL CHANGE DISEASE AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN ADULTS
Rao, Indu R.
Kohli, Harbir S.
Ramachandran, Raja
Gupta, K. L.
Minz, Ranjana W.
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 128 - 128
[44] Glomerular parietal epithelial expression of CD44 in minimal change nephrotic syndrome and primary focal segmental glomerulosclerosis: A clinico-pathological study
Paul, E. Nithin
Satish, Suchitha
Kelur, Kiran Krishnamurthy
Shetty, Manjunath Sanjeev
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2023, 66 (03) : 526 - 532
[45] Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases
Kronbichler, Andreas
Koenig, Paul
Busch, Martin
Wolf, Gunter
Mayer, Gert
Rudnicki, Michael
WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 (11-12) : 328 - 333
[46] Urinary matrix metalloproteinase-7 is a sensitive biomarker to evaluate renal tubular injury in patients with minimal change disease and focal segmental glomerulosclerosis
Yin, Dan-yang
Hou, Gai-ling
Yang, Xiao-qing
Bi, Liang-liang
Mei, Xiao-feng
Bai, Meng-ke
Zhou, Li
Zhu, Shan
Huang, Yan-jie
CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
[47] Age and prediction of remission and relapse of proteinuria and corticosteroid-related adverse events in adult-onset minimal-change disease: a retrospective cohort study
Shinzawa, Maki
Yamamoto, Ryohei
Nagasawa, Yasuyuki
Oseto, Susumu
Mori, Daisuke
Tomida, Kodo
Hayashi, Terumasa
Izumi, Masaaki
Fukunaga, Megumu
Yamauchi, Atsushi
Tsubakihara, Yoshiharu
Rakugi, Hiromi
Isaka, Yoshitaka
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (06) : 839 - 847
[48] Age and prediction of remission and relapse of proteinuria and corticosteroid-related adverse events in adult-onset minimal-change disease: a retrospective cohort study
Maki Shinzawa
Ryohei Yamamoto
Yasuyuki Nagasawa
Susumu Oseto
Daisuke Mori
Kodo Tomida
Terumasa Hayashi
Masaaki Izumi
Megumu Fukunaga
Atsushi Yamauchi
Yoshiharu Tsubakihara
Hiromi Rakugi
Yoshitaka Isaka
Clinical and Experimental Nephrology, 2013, 17 : 839 - 847
[49] Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 casesRituximab bei erwachsenen Patienten mit häufig-relapsierender/steroid-abhängiger Minimal Change Disease und fokal segmentaler Glomerulosklerose: Ein Bericht von 5 Fällen
Andreas Kronbichler
Paul König
Martin Busch
Gunter Wolf
Gert Mayer
Michael Rudnicki
Wiener klinische Wochenschrift, 2013, 125 : 328 - 333

← 1 2 3 4 5 →